MENU
PRLD
AS OF
Dec 24 closing price
Price
$2.23
Change
+$0.04 (+1.83%)
Capitalization
140.19M
83 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PRLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prelude Therapeutics (PRLD) Ownership - Who owns Prelude Therapeutics?

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
128
Web
https://www.preludetx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
140.19M
P/E Ratio
N/A
Total Cash
54.96M
Projected Growth
N/A
Total Debt
17.85M
Revenue
10.5M
Risk (Beta)
2.73
Dividend Yield
N/A
Total Cash/Share
0.87
Total Debt/Equity
N/A
Revenue/Share
0.14 USD as % of share price

Fundamentals

PRLD
Capitalization
140M
P/E Ratio
N/A
Risk (Beta)
2.73
Dividend Yield
N/A
Total Cash
55M
Total Cash/Share
0.87
Total Debt
17.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.14%
Revenue
10.5M
ROE
N/A
Book Value
58.5M
P/B Ratio
2.40
Cash Flow
N/A
Earnings
-1.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.21
Current Revenue Per Employee
49618.32
Dividends Per Share - Security
N/A
EBITDA
-119.27M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-76.56
Shares Held By Institutions
39.8M
Shares Outstanding - Current
62.9M
Total Liabilities
36.2M
Total Volume MTD
N/A
Value
1
Gain YTD
74.902
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PRLD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRLD showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for PRLD
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
175 Innovation Boulevard
Phone
+1 302 467-1280
Employees
128
Web
https://www.preludetx.com